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Two cases of inflammatory myofibroblastic tumor (IMT) of the bladder are reported here. Both patients were male and presented
with macroscopic hematuria; in the first case terminal hematuria was associated with irritative voiding symptoms. The second
case was a smoker with hematuria unresponsive to medical treatment and anemia. Clinical presentation, pathological features,
treatment, and prognosis are discussed. Due to rarity of this pathological condition, there are no guidelines concerning treatment
and follow-up. We present our follow-up scheme and highlight the use of laparoscopic partial cystectomy as a successful treatment
approach.
1. Introduction
Inflammatory myofibroblastic tumor of the bladder was first
described in 1980 by Roth [1]; it is a rare benign myofibrob-
lastic proliferation that has been given several designations,
including inflammatory pseudotumor, inflammatory pseu-
dosarcomatous fibromyxoid tumor, nodular fasciitis, pseu-
dosarcomatous myofibroblastic tumor, and fibromyxoid
pseudotumor [2].
Most of the patients are young, with a mean age of 38.9
years and a slightly female predominance of 51.7% in some
studies [3], while others report a male predominance of 9 : 8
[4]. The most common symptom is hematuria, followed by
irritative or obstructive voiding symptoms and lower abdom-
inal pain [2, 3, 5]. Tumor size descriptions range from 1.5 to
13 cm [2]. IMT etiology is still unknown; prior history of sur-
gery or instrumentation, trauma, and steroid use has been
associated with it but due to its rarity it remains uncertain
[3, 5].
Herein, we report two cases with different presentations
of this rare clinical entity.
2. Case Presentation
(1) A 38-year-old nonsmoking male presented with burning
micturition and terminal macroscopic hematuria for one
month period, with no other symptoms or previous relevant
medical history. Physical exam and routine blood profile were
normal. Pelvic ultrasound revealed an asymmetrical thicken-
ing of the right anterolateral bladder wall (maximum thick-
ness 23.5mm). Cystoscopy showed a well-defined solid lobu-
lated lesionwith a fibrinous exudate (Figure 1). It was biopsied
and sent to the Pathology Department. Microscopic exam-
ination revealed spindle cell proliferation with a fascicular
pattern admixed with inflammatory cells on a myxoid back-
ground (Figure 2). The immunohistochemistry study was
positive for vimentin, smooth muscle actin, and ALK-1 and
negative for desmin, PS100, and CD34. The diagnosis was an
IMT of the urinary bladder. On computed tomography (CT)
scan no local or lymph nodes invasion was detected. Laparo-
scopic partial cystectomy was performed, with a total dura-
tion of 100minutes, minimal blood loss, and no perioperative
complications.The histopathological examination confirmed
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Figure 1: First case tumor cystoscopic appearance.
Figure 2: Histological examination (hematoxylin-eosin staining;
magnification 10 × 40), showing spindle cell proliferation with a
fascicular pattern admixed with inflammatory cells on a myxoid
background.
the initial diagnosis, the tumor had 3.2 cm of largest diameter,
and margins were negative. Pelvic CT at 56 months after
surgery was also negative. At 58 months (4.8 years) after
surgery the patient is asymptomatic, with no frequency or
dysuria, and has no evidence of recurrence. Follow-up has
been made with biannual cystoscopy.
(2) A 56-year-old male, with a 50-pack year history of
smoking, was admitted from the urgency department for
painless gross hematuria with clots. In blood tests, anemia
(Hemoglobin 8.6 g/dL) was detected, no other abnormalities.
Urgent transurethral bladder resection/fulguration (TUBR)
was proposed to control the hematuria and remove bladder
clots, where cystoscopy showed a solid and wide base/sessile
lesion of the anterior wall. According to the histomorpholog-
ical features and the immunohistochemical profile (Figure 3),
similar to the first case, the histopathological diagnosis was an
IMT of the urinary bladder with muscularis mucosa infiltra-
tion. CT showed a 6 cm right anterolateral bladder wall thick-
ness, with involvement of the perivesical fat; no lymph nodes
or other lesions were identified (Figure 4). Laparoscopic par-
tial cystectomy was proposed to achieve total resection. The
partial cystectomy, combined with intraoperative cystoscopy
to identify mucosal abnormalities, was done in 160 minutes
without perioperative complications. The tumor margins
Figure 3: Histological examination of the second case (magnifica-
tion 10 × 20), positive ALK-1 staining.
Figure 4: CT-scan of the second case showing a bladder wall
thickening, with contrast enhancement.
were negative. At 14 months of follow-up, CT and cystoscopy
are free of recurrence signs. The patient has no storage or
voiding symptoms and accomplished a smoking cessation
program with success.
3. Discussion
Clinically and radiologically, IMT of the urinary bladder is
indistinguishable from other entities, it has a broad differen-
tial diagnosis ranging from reactive to neoplastic malignant
lesions, comprising postoperative spindle cell nodule, embry-
onal rhabdomyosarcoma, leiomyosarcoma or sarcomatoid
urothelial carcinoma [2, 6]. When compared to urothelial
bladder carcinoma, the most frequent bladder tumor, IMT
usually presents at younger age and spares the trigone [7].
Ultrasound findings are unspecific, and on CT IMT can
present as intraluminal polypoid or submucosal mass, with
variable density and, usually, early peripheral enhancement
[7, 8]. Perivesical fat stranding can also be present [8].
The final and definitive diagnosis can only be made by
histopathological examination and immunohistochemical/
molecular study, with IMT expressingmainly smoothmuscle
actin, desmin, and anaplastic lymphoma kinase (ALK-1)
[9]. Positive cytoplasmic immunostaining for ALK has been
identified in up to 89% of cases of IMT in the bladder [2].
In a recent systematic review the ALK was positive in 65% of
120 patients analyzed [3], but no conclusions where possible
about the difference between ALK positive or negative IMT
of the bladder.
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Despite being a benign lesion it can recidivate locally,
possibly due to muscularis mucosa invasion, described in
41% of the patients in a review by Montgomery et al. [9]. At
least one case of malignant IMT of the bladder with local
recurrence and multiple lymph node, bone, and soft tissue
metastases was reported [5].
There are few case reports concerning conservative ther-
apy in bladder IMT; in one case a successful reduction in the
size of a bladder IMT with anti-inflammatory regime (pred-
nisone and Cox-2 inhibitor) was achieved [10], while others
reported complete conservative treatment using ibuprofen
and amoxicillin/clavulanate potassium [11].
Complete local resection with negative surgical mar-
gins at pathology is the more advisable treatment and the
most important prognostic factor, which can be achieved
by transurethral resection (only if superficial) or partial
cystectomy. Concerning the possibility of recurrence it is
our opinion that partial cystectomy is more effective in total
removal of the lesion, as presented in this paper.
The first description of the laparoscopic approach in
partial cystectomy for IMT was done by Pradhan et al. in
2013 [12]; in our two cases we used a similar technique since
both tumors were located anteriorly without need for ureteral
mobilization. In Trendelenburg position, 4 transperitoneal
ports were introduced and, after bladder dissection, the
tumor was identified using the flexible cystoscope light and a
security margin was left.The bladder was closed in two layers
usingVicryl 0, a Foley catheter 16 Frwas left for ten days, and
a pelvic drain was left for 48 hrs. Our patients were discharge
after pelvic drain removal, at second postoperative day, with
no complications.
Laparoscopic partial cystectomy can play an important
role in the management of this rare bladder tumor, allowing
complete resection with few comorbidities and rapid recov-
ery in a pathology that mainly affects young patients.
Regarding follow-up, there are no standardized schemes
but it is advisable since this tumor has 25% of recurrence [7].
We adopt biannual urethrocystoscopy and CT every 2 years
for the first 5 years. One of the patients is now reaching five
years of follow-up and we are planning to change to annual
urine sample analysis and pelvic ultrasonography evaluation.
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